Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Tract Infections 2Infections 2Urinary Bladder Neoplasms 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pain 1Neutropenia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Hypokalemia 1Hypertension 1Hyperaldosteronism 1Herpes Simplex 1Hemophilia A 1

Interventions

ferric carboxymaltose 1Trastuzumab 1Oxaliplatin 1Fosfomycin 1Defecation 1Conservative Treatment 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Gastric Carcinoma × Fosfomycin × Clear all
NCT05226169 2026-04-03

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Asan Medical Center

Phase 3 Recruiting
330 enrolled
Gastrointestinal

Advanced Gastric Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡